Celastrol’s druggability, molecular targets, and nanocarrier delivery against chronic diseases

Announcing a new publication for Acta Materia Medica journal. Celastrol is an active compound from the root of Tripterygium wilfordii Hook F that shows great potential in the treatment of inflammation, cancer, neurodegeneration, diabetes, and obesity.

New oral insulin delivered via nano-carriers could soon replace injections

There are approximately 425 million people worldwide with diabetes. Approximately 75 million of these inject themselves with insulin daily.

January 19, 2024

Physician posture impacts patient experience and outcomes

A new study suggests that getting at a patient’s eye level when talking with them about their diagnosis or care can really make a difference.

July 26, 2024

Life expectancy gap between men and women widens in the U.S.

We’ve known for more than a century that women outlive men. But new research led by UC San Francisco and Harvard T.H. Chan School of

November 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.